© 2001 Journal of Clinical Pathology
Review
What we could do now: molecular pathology of gynaecological cancer
Department of Pathology, Duncan Building, Royal Liverpool University of Hospital, Daulby Street, Liverpool L69 3GA, UK
Correspondence to:
Professor Herrington c.s.herrington{at}liv.ac.uk
Gynaecological tumours exemplify many of the molecular paradigms of carcinogenesis. The clinical value of many of the molecular abnormalities present is now being tested and it is likely that the identification of at least some of these will become routine in the near future. This may help to refine diagnosis and guide treatment—for example, therapeutic vaccination for human papillomavirus related disease.
Key Words: gynaecology • cancer • papillomavirus
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Tomlinson, I
(2001). Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview. Mol. Pathol.
54: 201-202
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
